Stock CEL CELADON PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Celadon Pharmaceuticals Plc

Equities

CEL

GB00BDQYGP38

Market Closed - London S.E.
Other stock markets
 11:35:24 2024-07-05 am EDT 		5-day change 1st Jan Change
75 GBX 0.00% Intraday chart for Celadon Pharmaceuticals Plc -5.06% -34.78%
May. 23 Celadon Pharmaceuticals plc Announces Supply of Products to New US Customer CI
May. 14 Celadon Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Celadon ships to US; Oxford BioDynamics-Goodbody pact
AN
Celadon Pharmaceuticals plc Announces Supply of Products to New US Customer
CI
Headlam warns of loss; EnSilica predicts revenue rise
AN
Celadon Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Celadon raises GBP2 million, extends credit facility
AN
Celadon Pharmaceuticals Raises GBP2 Million via Fundraising
MT
Celadon hails early results of chronic pain trial
AN
Celadon Pharmaceuticals plc Announces the Results of an Early Economic Analysis of the Data Collected as Part of the Feasibility Study for Its Fully Approved Chronic Pain Clinical Trial
CI
Celadon announces start of cannabis supply for two UK companies
AN
Celadon Delivers Pharmaceutical-grade Product Under Two Orders; Stock Rises
MT
Celadon Pharmaceuticals plc Announces the First Supply of Its Pharmaceutical-Grade Product to the Two Commercial Contracts
CI
Celadon Pharma raises GBP2.0 million via placing
AN
Celadon Pharmaceuticals Wins Cannabis Product Supply Deal in Europe; Stock Surges
MT
Celadon shares rise on supply contract worth up to GBP26 million
AN
Celadon Pharmaceuticals plc Enters into Contract for the Commercial Supply of Its Pharmaceutical-Grade Cannabis Product with a Leading European Medicinal Cannabis Company
CI
Celadon Pharmaceuticals interim loss narrows; optimistic for future
AN
Earnings Flash (CEL.L) CELADON PHARMACEUTICALS Posts H1 Revenue GBP8,000
MT
Earnings Flash (CEL.L) CELADON PHARMACEUTICALS Posts H1 Loss GBX-7.20
MT
Celadon Pharmaceuticals Plc Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Celadon Pharmaceuticals Secures New Cannabis Product Deal in UK
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CEL Stock
  4. News Celadon Pharmaceuticals Plc
  5. Highlights